| Name | Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride |
|---|
| Description | Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatment of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
| References |
| Molecular Formula | C21H27ClN4O8 |
|---|---|
| Molecular Weight | 498.91 |
| Storage condition | -20°C |